8:05am ET
Investing
20 Companies Buying Back the Most Stock in 2016
Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to a whopping $161.4 billion.
GILD Coverage Page 28
12:25pm ET
Health and Healthcare
Gilead Sciences Bounces on Preliminary Results
Shares of Gilead Sciences Inc. (NASDAQ: GILD) saw make a handy gain just off of their 52-week low following the release of preliminary data from its HIV treatment. After the stock dropped about 17.5%…
Chris Lange 8:10am ET
Health and Healthcare
Short Sellers Become More Selective on Major Biotechs
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
8:10am ET
Health and Healthcare
7 Companies in the Fight to Defeat the Zika Virus
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable…
8:20am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
4:04pm ET
Investing
The 52-Week Low Club for Thursday
May 19, 2016: Here are four stocks trading with heavy volume among 81 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by nearly 2 to 1 while Nasdaq…
8:15am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
1:35pm ET
Health and Healthcare
Can Gilead Shares Still Really Rise to $150?
Gilead Sciences saw a sell-off after the company posted less than favorable earnings, but one analyst thinks that investors have spoken too soon.
Chris Lange 10:50am ET
Health and Healthcare
Analysts Make Major Changes to Top Biotech Ratings
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls by the week's end.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More
The top analyst upgrades, downgrades and initiations seen on Friday morning include Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital and Whiting Petroleum.
4:52pm ET
Health and Healthcare
Gilead Results Trip Over Both the Top and Bottom Lines
Gilead Sciences Inc. (NASDAQ: GILD) reported first-quarter financial results after the markets closed on Thursday. The company had $3.03 in earnings per share (EPS) on $7.79 billion in revenue compared to consensus…
Chris Lange 8:10am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The April 15 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
6:57am ET
Special Report
The World’s 15 Top Selling Drugs
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical companies generate an estimated $300…
9:50am ET
Investing
UBS Makes Major Changes to Equity Focus List for Q2
In a recent report, UBS made some significant changes to its Equity Focus list. The analysts look to go a touch more aggressive with the new additions.
9:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.